Beam Therapeutics, Inc. (BEAM)
27.72
-0.10
(-0.36%)
USD |
NASDAQ |
Dec 31, 16:00
27.71
-0.01
(-0.04%)
After-Hours: 20:00
Beam Therapeutics Research and Development Expense (TTM): 411.79M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| ANI Pharmaceuticals, Inc. | 56.05M |
| Intellia Therapeutics, Inc. | 407.11M |
| Regeneron Pharmaceuticals, Inc. | 5.097B |
| Amicus Therapeutics, Inc. | 142.29M |
| Repligen Corp. | 51.77M |